Transferrin-Bearing, Zein-Based Hybrid Lipid Nanoparticles for Drug and Gene Delivery to Prostate Cancer Cells.

Maeyouf, Khadeejah; Sakpakdeejaroen, Intouch; Somani, Sukrut; Meewan, Jitkasem; Ali-Jerman, Hawraa; Laskar, Partha; Mullin, Margaret; MacKenzie, Graeme; Tate, Rothwelle J; Dufès, Christine

Maeyouf, Khadeejah; Sakpakdeejaroen, Intouch; Somani, Sukrut; Meewan, Jitkasem; Ali-Jerman, Hawraa; Laskar, Partha; Mullin, Margaret; MacKenzie, Graeme; Tate, Rothwelle J; Dufès, Christine.

Afiliação

Maeyouf K; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Sakpakdeejaroen I; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Somani S; Faculty of Medicine, Thammasat University, Klong Nueng, Klong Luang, Pathumthani 12121, Thailand.
Meewan J; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Ali-Jerman H; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Laskar P; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Mullin M; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
MacKenzie G; Department of Chemistry, School of Science, Gandhi Institute of Technology and Management, Visakhapatnam 530045, Andhra Pradesh, India.
Tate RJ; Glasgow Imaging Facility, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Dufès C; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.

Pharmaceutics ; 15(11)2023 Nov 20.

Article em En | MEDLINE | ID: mdl-38004621

Palavras-chave

cancer therapy; delivery system; prostate cancer; transferrin; tumor targeting; zein-based hybrid lipid nanoparticles

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido